• 1
    Abacioglu U,Uzel O,Sengoz M,Turkan S,Ober A. Medulloblastoma in adults: treatment results and prognostic factors. Int J Radiat Oncol Biol Phys. 2002; 54: 855860.
  • 2
    Carrie C,Lasset C,Blay JY, et al. Medulloblastoma in adults: survival and prognostic factors. Radiother Oncol. 1993; 29: 301307.
  • 3
    Brandes AA,Ermani M,Amista P, et al. The treatment of adults with medulloblastoma: a prospective study. Int J Radiat Oncol Biol Phys. 2003; 57: 755761.
  • 4
    Chang CH,Housepian EM,Herbert CJr. An operative staging system and a megavoltage radiotherapeutic technique for cerebellar medulloblastomas. Radiology. 1969; 93: 13511359.
  • 5
    Tait DM,Thornton-Jones H,Bloom HJ,Lemerle J,Morris-Jones P. Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer. 1990; 26: 464469.
  • 6
    Galanis E,Buckner JC,Schomberg PJ,Hammack JE,Raffel C,Scheithauer BW. Effective chemotherapy for advanced CNS embryonal tumors in adults. J Clin Oncol. 1997; 15: 29392944.
  • 7
    Brandes AA,Palmisano V,Monfardini S. Medulloblastoma in adults: clinical characteristics and treatment. Cancer Treat Rev. 1999; 25: 312.
  • 8
    Brandes AA,Paris MK. Review of the prognostic factors in medulloblastoma of children and adults. Crit Rev Oncol Hematol. 2004; 50: 121128.
  • 9
    Kortmann RD,Brandes AA. Current and future strategies in the management of medulloblastoma in adults. Forum (Genova). 2003; 13: 99110.
  • 10
    Packer RJ,Gajjar A,Vezina G, et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol. 2006; 24: 42024208.
  • 11
    Carrie C,Lasset C,Alapetite C, et al. Multivariate analysis of prognostic factors in adult patients with medulloblastoma. Retrospective study of 156 patients. Cancer. 1994; 74: 23522360.
  • 12
    Prados MD,Warnick RE,Wara WM,Larson DA,Lamborn K,Wilson CB. Medulloblastoma in adults. Int J Radiat Oncol Biol Phys. 1995; 32: 11451152.
  • 13
    Chan AW,Tarbell NJ,Black PM, et al. Adult medulloblastoma: prognostic factors and patterns of relapse. Neurosurgery. 2000; 47: 623631; discussion 631–632.
  • 14
    Greenberg HS,Chamberlain MC,Glantz MJ,Wang S. Adult medulloblastoma: multiagent chemotherapy. Neuro-oncology. 2001; 3: 2934.
  • 15
    Tornesello A,Mastrangelo S,Piciacchia D, et al. Progressive disease in children with medulloblastoma/PNET during preradiation chemotherapy. J Neurooncol. 1999; 45: 135140.
  • 16
    Zeltzer PM,Boyett JM,Finlay JL, et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol. 1999; 17: 832845.
  • 17
    Bailey CC,Gnekow A,Wellek S, et al. Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. Med Pediatr Oncol. 1995; 25: 166178.
  • 18
    Kortmann RD,Kuhl J,Timmermann B, et al. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys. 2000; 46: 269279.
  • 19
    Taylor RE,Bailey CC,Robinson K, et al. Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study. J Clin Oncol. 2003; 21: 15811591.